DEF 14AThe Ballot
AN2 Therapeutics, Inc. files DEF 14A
Filed Apr 26, 2023 · 3y ago · Accession 0000950170-23-014794
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- AN2 Therapeutics, Inc.
- Ticker
- ANTX
- CIK
- 1880438
- Form type
- DEF 14A
- Filing date
- Apr 26, 2023
- Report date
- Jun 7, 2023
- Document
- antx-def14a-2022-final.htm
- Size
- 2.7 MB